Breaking News Instant updates and real-time market news.

RDS.A

Royal Dutch Shell

$49.22

-0.23 (-0.47%)

, RDS.B

Royal Dutch Shell

$52.04

-0.25 (-0.48%)

17:44
11/20/16
11/20
17:44
11/20/16
17:44

Chrysaor nears deal for $2B in Shell North Sea assets, Sunday Times says

Private oil firm Chrysaor is nearing an agreement for nearly $2B worth of Shell's North Sea assets, reports the Sunday Times. The company is likely to buy most but possibly not all of the North Sea fields Shell hopes to divest, sources told the publication. Reference Link

RDS.A

Royal Dutch Shell

$49.22

-0.23 (-0.47%)

RDS.B

Royal Dutch Shell

$52.04

-0.25 (-0.48%)

RDS.A Royal Dutch Shell
$49.22

-0.23 (-0.47%)

09/08/16
BERN
09/08/16
DOWNGRADE
BERN
Underperform
Repsol downgraded to Underperform from Market Perform at Bernstein
Bernstein analyst Oswald Clint downgraded Repsol (REPYY) based on his new analysis which shows that its upstream ROIC ranks sixth among the European integrated oil names he covers. The analyst says that Shell (RDS.A), BP (BP), and Eni (E) rank first, second, and third, respectively. He set an EUR11.30 price target on Repsol, down from EUR13 previously.
10/14/16
ADAM
10/14/16
DOWNGRADE
ADAM
Sell
Royal Dutch Shell downgraded to Sell from Hold At Canaccord
Canaccord downgraded Royal Dutch Shell to Sell from Hold based on the gap between the average free cash flow generation of Shell over the past two decades and the medium-term target. Canaccord said the company would require at least a five-fold improvement from the 20-year average and a ten-fold improvement from the 10 year average to make its medium-term goals.
10/14/16
10/14/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Royal Dutch Shell (RDS.A, RDS.B) downgraded to Sell from Hold at Canaccord with the firm citing the gap between the average free cash flow generation of Shell over the past two decades and the medium-term target. 2. bluebird bio (BLUE) downgraded to Sell from Hold at Cantor with analyst Elemer Piros saying he sees a lack of catalysts as he does not expect data to be announced at this year's American Society of Hematology conference to de-risk the hemoglobinopathy programs. 3. Fluor (FLR) downgraded to Neutral from Accumulate at Seaport Global with analyst Ryan Cassil citing persistently weaker global macroeconomic trends and expectations for a continuation of weaker project activity in 2017. 4. Boston Beer (SAM) downgraded to Hold from Buy at Berenberg. 5. Estee Lauder (EL) downgraded to Neutral from Overweight at Piper Jaffray after the firm's semi-annual proprietary "Taking Stock With Teens" survey. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/02/16
JPMS
11/02/16
UPGRADE
JPMS
Overweight
Royal Dutch Shell upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Christyan Malek upgraded Royal Dutch Shell to Overweight.
RDS.B Royal Dutch Shell
$52.04

-0.25 (-0.48%)

03/11/16
03/11/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Finisar (FNSR) upgraded to Buy at Craig-Hallum and B. Riley, following the company's Q3 results. Craig-Hallum analyst Richard Shannon was encouraged by guidance in a seasonally difficult part of Finisar's year and believes the company has reached the inflection point he has been waiting for. 2. Diamond Offshore (DO) upgraded to Neutral at Goldman and Piper Jaffray, with analysts citing an improved relative valuation, the company's balance sheet, and liquidity. 3. Cenovus Energy (CVE) upgraded to Conviction Buy at Goldman by analyst Neil Mehta, who cited the company's strong 2017 free cash flows, improving commodity prices, high quality assets, and relative underperformance. 4. Weatherford (WFT) upgraded to Buy at Goldman with analyst Waqar Syed saying Weatherford will be a beneficiary of an expected recovery in US land drilling activity in 2017. He added that investors will benefit from cost cutting and restructuring measures taken over the past two years. 5. Royal Dutch Shell (RDS.A) upgraded to Conviction Buy at Goldman due to expectations for a growing dividend yield driven by cost cutting, capital discipline, the realization of synergies, and rising oil prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/01/16
RBCM
08/01/16
DOWNGRADE
RBCM
Sector Perform
Royal Dutch Shell downgraded on valuation, debt at RBC Capital
As noted earlier, RBC Capital downgraded Royal Dutch Shell to Sector Perform from Outperform. As reasons for the downgrade, analyst Biraj Borkhataria cited valuation and the company's debt burden.

TODAY'S FREE FLY STORIES

BLK

BlackRock

$587.22

8 (1.38%)

, SNBR

Sleep Number

$37.00

-1.11 (-2.91%)

14:25
01/19/18
01/19
14:25
01/19/18
14:25
Hot Stocks
BlackRock reports 12.6% passive stake in Sleep Number »

In a regulatory filing,…

BLK

BlackRock

$587.22

8 (1.38%)

SNBR

Sleep Number

$37.00

-1.11 (-2.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

LEG

Leggett & Platt

$48.15

-0.21 (-0.43%)

14:20
01/19/18
01/19
14:20
01/19/18
14:20
Options
Put buying in Leggett and Platt »

Put buying in Leggett and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:20
01/19/18
01/19
14:20
01/19/18
14:20
General news
Fedspeak will be truncated next week »

Fedspeak will be…

$NSD

NASDAQ Market Internals

14:17
01/19/18
01/19
14:17
01/19/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
01/19/18
01/19
14:16
01/19/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$179.80

2.2 (1.24%)

, AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

14:08
01/19/18
01/19
14:08
01/19/18
14:08
Periodicals
Facebook not bidding for Thursday Night Football rights, Bloomberg reports »

Facebook (FB) has decided…

FB

Facebook

$179.80

2.2 (1.24%)

AMZN

Amazon.com

$1,293.32

-1.68 (-0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

HPQ

HP Inc.

$23.62

0.33 (1.42%)

14:06
01/19/18
01/19
14:06
01/19/18
14:06
Conference/Events
HP Inc. to hold a webcast »

Global Head of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 22

    Jan

RENN

Renren

$10.96

-0.16 (-1.44%)

14:05
01/19/18
01/19
14:05
01/19/18
14:05
Options
Renren call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$3.66

0.03 (0.83%)

14:04
01/19/18
01/19
14:04
01/19/18
14:04
Hot Stocks
Tonix: Horsepox virus showed protection vs. lethal vaccinia infection in study »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLK

BlackRock

$587.11

7.89 (1.36%)

, CIR

Circor

$53.40

1.12 (2.14%)

14:04
01/19/18
01/19
14:04
01/19/18
14:04
Hot Stocks
BlackRock reports 12.6% passive stake in Circor »

In a regulatory filing,…

BLK

BlackRock

$587.11

7.89 (1.36%)

CIR

Circor

$53.40

1.12 (2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 22

    Feb

VIA

Viacom

$39.70

1.85 (4.89%)

, FOXA

21st Century Fox

$36.18

-0.93 (-2.51%)

14:04
01/19/18
01/19
14:04
01/19/18
14:04
Hot Stocks
Box Office Battle: 'Jumanji,' 'The Post' expected to hold off '12 Strong' »

Still expected to remain…

VIA

Viacom

$39.70

1.85 (4.89%)

FOXA

21st Century Fox

$36.18

-0.93 (-2.51%)

LGF.B

Lionsgate

$33.25

0.41 (1.25%)

VIAB

Viacom

$33.95

1.99 (6.23%)

CMCSA

Comcast

$41.85

0.17 (0.41%)

CMCSK

Comcast

LGF.A

Lionsgate

$35.22

0.72 (2.09%)

TWX

Time Warner

$92.90

-0.07 (-0.08%)

DIS

Disney

$110.18

-0.24 (-0.22%)

SNE

Sony

$49.80

0.63 (1.28%)

FOX

21st Century Fox

$35.73

-0.76 (-2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

BLK

BlackRock

$586.98

7.76 (1.34%)

, BXS

BancorpSouth

$34.90

0.35 (1.01%)

14:02
01/19/18
01/19
14:02
01/19/18
14:02
Hot Stocks
BlackRock reports 10.2% passive stake in BancorpSouth »

In a regulatory filing,…

BLK

BlackRock

$586.98

7.76 (1.34%)

BXS

BancorpSouth

$34.90

0.35 (1.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 25

    Jan

14:00
01/19/18
01/19
14:00
01/19/18
14:00
General news
Action Economics Survey results: »

Action Economics Survey…

BASFY

BASF

$29.54

0.825 (2.87%)

, BAYRY

Bayer

$31.82

0.015 (0.05%)

13:57
01/19/18
01/19
13:57
01/19/18
13:57
Periodicals
Breaking Periodicals news story on BASF, Bayer »

Capitol Forum says BASF,…

BASFY

BASF

$29.54

0.825 (2.87%)

BAYRY

Bayer

$31.82

0.015 (0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 25

    Mar

13:55
01/19/18
01/19
13:55
01/19/18
13:55
General news
SF Fed moderate Williams said economic tailwinds »

SF Fed moderate Williams…

OCPNY

Olympus Corp

$38.27

-0.12 (-0.31%)

13:54
01/19/18
01/19
13:54
01/19/18
13:54
Hot Stocks
Judge grants new trial for Bigler Family vs. Olympus wrongful-death case »

A King County court has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$77.99

0.6 (0.78%)

13:52
01/19/18
01/19
13:52
01/19/18
13:52
Periodicals
Citi plans to have post-Brexit trading hub running by year end, Bloomberg says »

Citigroup intends to have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 24

    Jan

CANF

Can-Fite BioPharma

$1.76

0.01 (0.57%)

13:50
01/19/18
01/19
13:50
01/19/18
13:50
Conference/Events
Can-Fite BioPharma participates in lunch meeting with Philadelphia Securities »

Luncheon Meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

13:50
01/19/18
01/19
13:50
01/19/18
13:50
Options
VIX slips on a relatively quiet monthly expiration »

VIX slips on a relatively…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:50
01/19/18
01/19
13:50
01/19/18
13:50
General news
Oil Action: Baker-Hughes »

Oil Action: Baker-Hughes…

KMI

Kinder Morgan

$18.97

-0.045 (-0.24%)

13:45
01/19/18
01/19
13:45
01/19/18
13:45
Options
Post earnings premium seller collects $13M in KinderMorgan »

Post earnings premium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$91.92

1.61 (1.78%)

13:45
01/19/18
01/19
13:45
01/19/18
13:45
Options
Incyte call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

PRQR

ProQR Therapeutics

13:31
01/19/18
01/19
13:31
01/19/18
13:31
Conference/Events
ProQR Therapeutics to h old an investor event »

Investor Event will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

CMC

Commercial Metals

$24.83

-0.26 (-1.04%)

13:30
01/19/18
01/19
13:30
01/19/18
13:30
Options
Second day of call buying in Commercial Metals »

Second day of call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLEX

Flex

$19.61

0.17 (0.87%)

13:25
01/19/18
01/19
13:25
01/19/18
13:25
Options
Flex call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.